Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Barr Laboratories halts shipment of warfarin educational materials

Aug. 6, 1997

No Comments

Generic warfarin shipments begin

Aug. 4, 1997

No Comments

Picotamide suppresses ACE inhibitor-induced cough

July 29, 1997

No Comments

Clinical PK/PD study of TxA2 antagonist

July 28, 1997

No Comments

Joint venture established for transgenic ATIII

July 25, 1997

No Comments

Microbix receives milestone payment under ThromboClear agreement with Gensia

July 25, 1997

No Comments

Novel fibrinogen/integrin receptor antagonists described by Merck KGaA

July 22, 1997

No Comments

DuPont Merck prepares anticoagulant aminoboronic acids

July 21, 1997

No Comments

Fibrinogen-antagonistic oxopiperazine derivatives from Yamanouchi

July 17, 1997

No Comments

Potent, orally active fibrinogen antagonist developed at Merck & Co.

July 17, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Hematologic
RSS

Barr Laboratories halts shipment of warfarin educational materials

Generic warfarin shipments begin

Picotamide suppresses ACE inhibitor-induced cough

Clinical PK/PD study of TxA2 antagonist

Joint venture established for transgenic ATIII

Microbix receives milestone payment under ThromboClear agreement with Gensia

Novel fibrinogen/integrin receptor antagonists described by Merck KGaA

DuPont Merck prepares anticoagulant aminoboronic acids

Fibrinogen-antagonistic oxopiperazine derivatives from Yamanouchi

Potent, orally active fibrinogen antagonist developed at Merck & Co.

Today's news in brief

Today's news in brief

In muscular dystrophies, gene therapies race the clock

Bridgebio, with FDA approval, faces Pfizer in ATTR

‘Evo’ AI can design complete genomes

Hematologic RSS

Hematologic
RSS